Clinical Trials Directory

Trials / Terminated

TerminatedNCT02887118

Dense Red Blood Cells in Sickle Cell Children

Quantitative and Prognostic Evaluation of Dense Red Blood Cells in Sickle Cell Children: Single-center Study From the Creteil (France) Pediatric Cohort

Status
Terminated
Phase
Study type
Observational
Enrollment
82 (actual)
Sponsor
Centre Hospitalier Intercommunal Creteil · Academic / Other
Sex
All
Age
18 Months – 18 Years
Healthy volunteers
Not accepted

Summary

Quantitative and prognostic evaluation of dense red blood cells in sickle cell children: preliminary single center study from the Creteil pediatric cohort.

Detailed description

An association between red blood cell density and hemolytic parameters, and clinical manifestations has been demonstrated in adults with sickle cell anemia. This factor has not been studied in children. The identification of predictive biomarkers of disease severity, especially of specific pediatric complications (cerebral vasculopathy, splenic sequestration, Dactylitis) would be useful for optimal care of the children and early intensification Red blood cell density might be one of these prognostic factors.

Conditions

Timeline

Start date
2015-12-01
Primary completion
2019-07-07
Completion
2019-07-07
First posted
2016-09-01
Last updated
2020-07-10

Locations

1 site across 1 country: France

Source: ClinicalTrials.gov record NCT02887118. Inclusion in this directory is not an endorsement.

Dense Red Blood Cells in Sickle Cell Children (NCT02887118) · Clinical Trials Directory